Recall will shift buying preferences, survey finds

NEW YORK – Providers expect to permanently shift an average of 56% of their Philips flow generator purchases and an average of 23.1% of their Philips mask purchases to other companies due to the recall, according to Needham’s 3Q21 HME Sleep and Oxygen Survey. 

“And ResMed looks likely to be a beneficiary of this share movement,” Needham states. “Over the near-term, respondents expect ResMed’s share of their flow generator purchases to increase by 3.7% and its share of their mask purchases to increase by 2%.” 

Needham received responses from 71 providers. 

Other highlights from the survey: 

• Providers report that prices have increased by an average of 6.3% since Philips announced the recall on June 14. 
• Providers report they have been able to, on average, only purchase the following portions of their desired flow generator volumes for delivery within their required timeframes: Fisher & Paykel 7%, Philips 10.3%, ResMed 45.4%. 
• Fifty percent of providers believe the recall will divert resources from their resupply businesses and result in lower resupply sales.